8) Enabling Science
Abstract
Enables the accelerated development and deployment of therapeutics and prophylactics to the warfighter for protection against CWAs by leveraging technological advances to more efficiently assess the safety and efficacy of new candidates for IND submission. Efforts in this area include the development of anticholinergics, anticonvulsants, neuroprotectants, and delivery technologies to deliver therapeutics across the blood brain barrier (BBB). Efforts in this area establish therapeutic candidate libraries and pipelines using high throughput screening, artificial intelligence based drug design, and predictive toxicology.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2022
- Source ID
- ddfe7931e96780a2977f0160e3e7d09a